APA (7th ed.) Citation

JS, R., G, T., S, D., N, P., N, G., SJ, W., & GD, Y. (2005). VEGF trap as a novel antiangiogenic treatment currently in clinical trials for cancer and eye diseases, and VelociGene- based discovery of the next generation of angiogenesis targets. Cold Spring Harbor symposia on quantitative biology, 70, 411. https://doi.org/10.1101/sqb.2005.70.052

Chicago Style (17th ed.) Citation

JS, Rudge, Thurston G, Davis S, Papadopoulos N, Gale N, Wiegand SJ, and Yancopoulos GD. "VEGF Trap as a Novel Antiangiogenic Treatment Currently in Clinical Trials for Cancer and Eye Diseases, and VelociGene- Based Discovery of the Next Generation of Angiogenesis Targets." Cold Spring Harbor Symposia on Quantitative Biology 70 (2005): 411. https://doi.org/10.1101/sqb.2005.70.052.

MLA (9th ed.) Citation

JS, Rudge, et al. "VEGF Trap as a Novel Antiangiogenic Treatment Currently in Clinical Trials for Cancer and Eye Diseases, and VelociGene- Based Discovery of the Next Generation of Angiogenesis Targets." Cold Spring Harbor Symposia on Quantitative Biology, vol. 70, 2005, p. 411, https://doi.org/10.1101/sqb.2005.70.052.